Ukr.Biochem.J. 2015; Volume 87, #2, March-April

Association of allele variants of receptor gene of androgens (by the number of CAG-repeats) with androgen dependent hormonal metabolic indices of the organism

V. V. Korpachev, S. V. Melnychenko, R. G. Lukashova

State Institution V. Р. Komisarenko Institute of Endocrinology and Metabolism,
National Academy of Medical Sciences of Ukraine, Kyiv;
e-mail: vitascovna@gmail.com

This review discusses up-to-date conceptions concerning an association of androgen receptor gene (AR) allele (by the number of CAG-repeats) variations with the change of the receptor activity in humans. Different contradictory experiment results concerning the AR function dependence on the number of CAG-repeats have been analyzed. The authors discuss this problem paying mostly their attention to the interrelation between the number of CAG-repeats  and indicators of glucose and lipid metabolism in males and females.

Ключевые слова: , , , , , ,


Ссылки:

  1. Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009 Dec;5(12):673-81. Epub 2009 Oct 27. Review. [pm id="19859074"], [cr id="http://dx.doi.org/10.1038/nrendo.2009.212"]
  2. Diedov I. I., Kalinchenko S. Yu. Aged-dependent androgen deficiency in men. Moscow: Practicheskaya meditsina, 2006; 240 p. (In Russian).
  3. Jääskeläinen J. Molecular biology of androgen insensitivity. Mol Cell Endocrinol. 2012 Apr 16;352(1-2):4-12. Epub 2011 Aug 17. Review. [pm id="21871529"], [cr id="http://dx.doi.org/10.1016/j.mce.2011.08.006"]
  4. Carruthers M. Testosterone deficiency syndrome: cellular and molecular mechanism of action. Curr Aging Sci. 2013 Feb;6(1):115-24. Review. [pm id="23237597"]
  5. Tronko M. D., Korpachova-Zinych O. V. Steroid hormones and diabetes. Kyiv: Knyga-plus, 2010; 198 p. (In Russian).
  6. San Millán J. L., Cordớn M., Villuendas G., Sancho J., Peral B., Escobar-Morreale H. F. Association of polycystic ovary syndrome with genomic variations related to insulin resistance, type 2 diabetes mellitus, and obesity. J. Clin. Endocrinol. Metab. 2004;89(6):2640-2646.
  7. Barber TM, Franks S. Genetics of polycystic ovary syndrome. Front Horm Res. 2013;40:28-39. Epub 2012 Oct 18. Review. [pm id="24002403"], [cr id="http://dx.doi.org/10.1159/000341682"]
  8. Nieschlag E., Nieschlag S. Andrology: Male reproductive health and dysfunction. Springer, London. 2010.
  9. Shang Y, Myers M, Brown M. Formation of the androgen receptor transcription complex. Mol Cell. 2002 Mar;9(3):601-10. Erratum in: Mol Cell. 2003 Jun;11(6):1697. [pm id="11931767"]
  10. Skyarpe P. A. Androgen receptor CAG and GGN polymorphisms in vivo and in vitro (University of Tromso, A thesis submitted for the degree of philosophiae doctor). Tromso, Norway. 2012; 59 p.
  11. Gao W, Bohl CE, Dalton JT. Chemistry and structural biology of androgen receptor. Chem Rev. 2005 Sep;105(9):3352-70. Review. [pm id="16159155"], [pmc id="PMC2096617"]
  12. Mauvais-Jarvis F. Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesity. Trends Endocrinol Metab. 2011 Jan;22(1):24-33. Epub 2010 Nov 5. Review. [pm id="21109497"], [pmc id="PMC3011051"], [cr id="http://dx.doi.org/10.1016/j.tem.2010.10.002"]
  13. Dati E, Baroncelli GI, Mora S, Russo G, Baldinotti F, Parrini D, Erba P, Simi P, Bertelloni S. Body composition and metabolic profile in women with complete androgen insensitivity syndrome. Sex Dev. 2009;3(4):188-93. Epub 2009 Sep 11. [pm id="19752598"], [cr id="http://dx.doi.org/10.1159/000228719"]
  14. Kalyani RR, Dobs AS. Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes. 2007 Jun;14(3):226-34. Review. [pm id="17940444"]
  15. Yong EL, Ghadessy F, Wang Q, Mifsud A, Ng SC. Androgen receptor transactivation domain and control of spermatogenesis. Rev Reprod. 1998 Sep;3(3):141-4. Review. [pm id="9829547"]
  16. Gobinet J., Pujol N., Sultan C. Molecular action of androgens. Mol. Cell. Endocrinol. 2002;198:15-24.
  17. Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol. 2002 Jul 1;20(13):3001-15. Review. [pm id="12089231"]
  18. Lindzey Y., Kumar M. V., Grossman M., young C., Tindal D. J. Molecular mechanisms of androgen action. Vitam. Horm. 1994;49:383-432.
  19. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev. 1995 Jun;16(3):271-321. Review. Erratum in: Endocr Rev 1995 Aug;16(4):546. [pm id="7671849"]
  20. Kuiper G. G., Faber P. W., van Rooij H. C., van der Korput J. A., Ris-Stalpers C., Klaasen P., Trapman J., Brinkman A. O. Structural organization of the human androgen receptor gene. J. Mol. Endocrinol. 1989;2:R1-R4.
  21. Claessens F, Denayer S, Van Tilborgh N, Kerkhofs S, Helsen C, Haelens A. Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal. 2008 Jun 27;6:e008. Review. [pm id="18612376"], [pmc id="PMC2443950"], [cr id="http://dx.doi.org/10.1621/nrs.06008"]
  22. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991 Jul 4;352(6330):77-9. [pm id="2062380"]
  23. Wisniewski A. B., Migeon C. J., Meyer-Bahlburg H. F., Gearhart G. P., Berkovitz G. D., Brown T. R., Money J. Complete androgen insensitivity syndrome: Long-tern medical, surgical, and psychosexual outcome. J. Clin. Endocrinol. Metab. 2000;85:2664-2669.
  24. Zitzmann M. The role of the CAG repeat androgen receptor polymorphism in andrology. Front Horm Res. 2009;37:52-61. Review. [pm id="19011288"], [cr id="http://dx.doi.org/10.1159/000175843"]
  25. Crabbe P., Bogaert V., De Bacquer D., Goemaere S., Zmierczak H., Kaufman J. M. Part of the interindividual variation in serum testosterone level in healthy man reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism. J. Clin. Endocrinol. Metab. 2007;92(9):3604-3610.
  26. Schoenberg M. P., Hakimi Y. M., Wang S., Bove G. S., Epstein J. I., Fischbeck K. H., Isaaks W. B., Walsh P. C., Barrack E. P. Microsatellite mutation (CAG24→18) in the androgen receptor gene in human prostate cancer. Biochem. Biophys. Res. Commun. 1994;198(1):74-80.
  27. Klocker H., Gromoll J., Cato A. C. B. The androgen receptor: molecular biology. In “Testosterone, Action, Deficiency, Substitution”, Ed. Behre H. M., Cambridge, UK, Cambridge University Press, 2004:39-92.
  28. Chamberlain NL, Driver ED, Miesfeld RL. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994 Aug 11;22(15):3181-6. [pm id="8065934"], [pmc id="PMC310294"]
  29. Beilin J, Ball EM, Favaloro JM, Zajac JD. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol. 2000 Aug;25(1):85-96. [pm id="10915221"]
  30. Zitzmann M, Brune M, Kornmann B, Gromoll J, Junker R, Nieschlag E. The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clin Endocrinol (Oxf). 2001 Nov;55(5):649-57. [pm id="11894977"]
  31. Ding D, Xu L, Menon M, Reddy GP, Barrack ER. Effect of a short CAG (glutamine) repeat on human androgen receptor function. Prostate. 2004 Jan 1;58(1):23-32. [pm id="14673949"]
  32. Madjunkova S, Eftimov A, Georgiev V, Petrovski D, Dimovski A, Plaseska-Karanfilska D. CAG Repeat Number in the Androgen Receptor Gene and Prostate Cancer. Balkan J Med Genet. 2012 Jun;15(1):31-6. [pm id="24052720"], [pmс id="PMC3776652"], [cr id="http://dx.doi.org/10.2478/v10034-012-0005-z"]
  33. Tosh D., Panda B., Rao T.N., Babu A., Satti V., Raghnadharao D., Singh L., Rao L. CAG and GGN repeat length polymorphism of androgen receptor gene in women with breast cancer: a case-control study from South India. J. Cancer Therapy. 2012;3:741-748.
  34. Baculescu N. The role of androgen receptor activity mediated by the CAG repeat polymorphism in the pathogenesis of PCOS. J Med Life. 2013 Mar 15;6(1):18-25. Epub 2013 Mar 25. [pm id="23599814"], [pmс id="PMC3624640"]
  35. Lin LH, Baracat MC, Maciel GA, Soares JM Jr, Baracat EC. Androgen receptor gene polymorphism and polycystic ovary syndrome. Int J Gynaecol Obstet. 2013 Feb;120(2):115-8. Epub 2012 Nov 24. Review. [pm id="23182796"], [cr id="http://dx.doi.org/10.1016/j.ijgo.2012.08.016"]
  36. Fesaĭ OA, Kravchenko SA, Tyrkus MIa, Makukh GV, Zinchenko VM, Strelko GV, Livshits LA. Androgen receptor CAG gene polymorphism in men with azoospermia and oligozoospermia in Ukraine. Tsitol Genet. 2009 Nov-Dec;43(6):45-51. Russian.  [pm id="20458976"]
  37. Fujimoto Y., Hirose R., Sakaguchi H., Tamaya T. Expression of size- polymorphic androgen receptor (AR) gene in ovarian endometriosis according the number of cytosine, adenine and guanine (CAG) repeat in AR alleles. Steroids. 1999;64(8):526-529.
  38. Möhlig M, Jürgens A, Spranger J, Hoffmann K, Weickert MO, Schlösser HW, Schill T, Brabant G, Schüring A, Pfeiffer AF, Gromoll J, Schöfl C. The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome. Eur J Endocrinol. 2006;Jul;155(1):127-30.
  39. Tirabassi G., Muti N., Corona G., Maggi M., Balercia G. Androgen receptor gene CAG repeat polymorphism independently influences recovery of male sexual function after testosterone replacement therapy in postsurgical hypogonadotropic hypogonadism. J. Sex Med. 2014;11:1302-1308.
  40. Canale D, Caglieresi C, Moschini C, Liberati CD, Macchia E, Pinchera A, Martino E. Androgen receptor polymorphism (CAG repeats) and androgenicity. Clin Endocrinol (Oxf). 2005 Sep;63(3):356-61. Erratum in: Clin Endocrinol (Oxf). 2005 Oct;63(4):482. [pm id="16117826"]
  41. Davis-Dao CA, Tuazon ED, Sokol RZ, Cortessis VK. Male infertility and variation in CAG repeat length in the androgen receptor gene: a meta-analysis. J Clin Endocrinol Metab. 2007 Nov;92(11):4319-26. Epub 2007 Aug 7. [pm id="17684052"]
  42. Huhtaniemi I. T., Pye S. R., Limer K. L., Thomson W., O’Neill T. W., Platt H., Payne D., John S. L., Jiang M., Boonen S., Borghs H.,  Vanderschueren D., Adams J. E., Ward K. A., Bartfai G., Casanueva F., Finn J. D., Forti G., Giwercman A., Han Th. S., Kula K., Lean M. E. J., Pendleton N., Punab M., Silman A. J., Wu F. C. W., European Male Ageing Study Group. Increased estrogen rather that decreased action is associated with longer androgen receptor CAG repeats. J. Clin. Endocrinol. Metab. 2009;94(1):277-284.
  43. Sverdlov E. D. Considerations on structural molecular genetics. Look at the life through the genomic window. М.: Nauka, 2009; 525 p. (In Russian).
  44. Thomas PS Jr, Fraley GS, Damian V, Woodke LB, Zapata F, Sopher BL, Plymate SR, La Spada AR. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy. Hum Mol Genet. 2006 Jul 15;15(14):2225-38. Epub 2006 Jun 13. Erratum in: Hum Mol Genet. 2006 Oct 1;15(19):2972. Damien, Vincent [corrected to Damian, Vincent]. [pm id="16772330"]
  45. Ilarioshkin S. N. DNA-diagnostics and medico-genetic consultations. Moscow: Meditsinskoye informatsionnoye agentstvo. 2004; 207 p. (In Russian).
  46. Esteban E., Rodon N., Via M., Gonzales-Perez E., Santamaria J., Dugoujon J. M., Chennawi F. E., Melhaoui M., Cherkaoui M., Vona G., Harich N., Maral P. Androgen receptor CAG and GGC polymorphism in Mediterranean: repeat dynamics and population relationships. J. Hum. Genet. 2006;51(2):129-136.
  47. Namiki M, Ueno S, Kitagawa Y, Fukagai T, Akaza H. Effectiveness and adverse effects of hormonal therapy for prostate cancer: Japanese experience and perspective. Asian J Androl. 2012 May;14(3):451-7. Epub 2012 Mar 26. Review. [pm id="22447200"], [pmc id="PMC3722884"], [cr id="http://dx.doi.org/10.1038/aja.2011.121"]
  48. Sasaki M, Kaneuchi M, Sakuragi N, Fujimoto S, Carroll PR, Dahiya R. The polyglycine and polyglutamine repeats in the androgen receptor gene in Japanese and Caucasian populations. Biochem Biophys Res Commun. 2003 Dec 26;312(4):1244-7. [pm id="14652007"]
  49. Colangelo LA, Sharp L, Kopp P, Scholtens D, Chiu BC, Liu K, Gapstur SM. Total testosterone, androgen receptor polymorphism, and depressive symptoms in young black and white men: the CARDIA Male Hormone Study. Psychoneuroendocrinology. 2007 Sep-Nov;32(8-10):951-8. Epub 2007 Jul 30. [pm id="17659846"], [pmc id="PMC2139978"]
  50. Schneider G., Zitzmann M., Gromoll J., Ladwig K. H., Berger K. The relation between sex hormone levels, the androgen receptor CAGn-polymorphism and depression and mortality in older men in a community study. Psychoneuroendocrinology. 2013;38(10):2083-2090.
  51. T'Sjoen GG, De Vos S, Goemaere S, Van Pottelbergh I, Dierick M, Van Heeringen C, Kaufman JM. Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men. J Am Geriatr Soc. 2005 Apr;53(4):636-42. [pm id=" PubMed PMID: 15817010"]
  52. Seidman SN, Araujo AB, Roose SP, McKinlay JB. Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry. 2001 Sep 1;50(5):371-6. [pm id="11543741"]
  53. Geng YG, Su QR, Su LY, Chen Q, Ren GY, Shen SQ, Yu AY, Xia GY. Comparison of the polymorphisms of androgen receptor gene and estrogen alpha and beta gene between adolescent females with first-onset major depressive disorder and controls. Int J Neurosci. 2007 Apr;117(4):539-47. [pm id="17365134"]
  54. Lind JM, Chiu C, Ingles J, Yeates L, Humphries SE, Heather AK, Semsarian C. Sex hormone receptor gene variation associated with phenotype in male hypertrophic cardiomyopathy patients. J Mol Cell Cardiol. 2008 Aug;45(2):217-22. Epub 2008 Jul 9. [pm id="18617186"], [cr id="http://dx.doi.org/10.1016/j.yjmcc.2008.05.016"]
  55. Alevizaki M, Cimponeriu AT, Garofallaki M, Sarika HL, Alevizaki CC, Papamichael C, Philippou G, Anastasiou EA, Lekakis JP, Mavrikakis M. The androgen receptor gene CAG polymorphism is associated with the severity of coronary artery disease in men. Clin Endocrinol (Oxf). 2003 Dec;59(6):749-55. [pm id="14974917"]
  56. Zitzmann M, Nieschlag E. Androgens and vascular function. J Endocrinol Invest. 2003 Aug;26(8):767-9. [pm id="14669835"]
  57. MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy. Int J Cancer. 2010 Jun 15;126(12):2935-46. [pm id="19739075"], [cr id="http://dx.doi.org/10.1002/ijc.24892"]
  58. Kalyani RR, Franco M, Dobs AS, Ouyang P, Vaidya D, Bertoni A, Gapstur SM, Golden SH. The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women. J Clin Endocrinol Metab. 2009 Nov;94(11):4127-35. Epub 2009 Sep 29. [pm id="19789205"], [pmc id="PMC2775652"], [cr id="http://dx.doi.org/10.1210/jc.2009-0910"]
  59. Brum IS, Spritzer PM, Paris F, Maturana MA, Audran F, Sultan C. Association between androgen receptor gene CAG repeat polymorphism and plasma testosterone levels in postmenopausal women. J Soc Gynecol Investig. 2005 Feb;12(2):135-41. [pm id="15695110"]
  60. Rexrode KM, Ridker PM, Hegener HH, Buring JE, Manson JE, Zee RY. Genetic variation of the androgen receptor and risk of myocardial infarction and ischemic stroke in women. Stroke. 2008 May;39(5):1590-2. Epub 2008 Mar 6. [pm id="18323476"], [cr id="http://dx.doi.org/10.1161/STROKEAHA.107.508218"]
  61. Trevison T. G., Shackelton R., Araujo A. B., Morley J. E., Williams R. E., Clark R. V., McKinlay J. B. Frailty, serum androgens, and the CAG repeat polymorphism: results from the Massachusetts male aging study. J. Clin. Endocrinol. Metab. 2010;95(6):2746-2754.
  62.  Voorhoeve P. G., Mechelen W., Uitterlinden A. G., Delemarre-van de Waal H. A., Lamberts S. W. Androgen receptor gene CAG repeat polymorphism in longitudinal height and body composition in children and adolеscents. Clin. Endocrinol. (Oxf). 2011;74(6):732-735.
  63. Yeap BB, Chubb SA, Hyde Z, Jamrozik K, Hankey GJ, Flicker L, Norman PE. Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study. Eur J Endocrinol. 2009 Oct;161(4):591-8. Epub 2009 Aug 6. [pm id="19661128"], [cr id="http://dx.doi.org/10.1530/EJE-09-0348"]
  64. Ponce-González JG, Guadalupe-Grau A, Rodríguez-González FG, Dorado C, Olmedillas H, Fuentes T, Rodríguez-García L, Díaz-Chico BN, Calbet JA. Androgen receptor gene polymorphisms and the fat-bone axis in young men and women. J Androl. 2012 Jul-Aug;33(4):644-50. Epub 2011 Sep 22. [pm id="21940984"], [cr id="http://dx.doi.org/10.2164/jandrol.111.014415"]
  65. Rodrígez-González G., Ramírez-Moreno R., Pérez P., Bilbao P., López-Ríos L., Díaz-Chico J. C., Lara P. C., Serra-Majem L., Chirino R., Díaz-Chico B. N. The GGN and CAG repeat polymorphisms in the exon-1 of the androgen receptor gene are, respectively, associated with insulin resistance in men and with dyslipidemia in women. J. Steroid Biochem. Mol. Biol. 2009;113:202-208.
  66. Saad F. The role of testosterone in type 2 diabetes and metabolic syndrome in men. Arq Bras Endocrinol Metabol. 2009 Nov;53(8):901-7. Review. [pm id="20126841"]
  67. Li C, Ford ES, Li B, Giles WH, Liu S. Association of testosterone and sex hormone-binding globulin with metabolic syndrome and insulin resistance in men. Diabetes Care. 2010 Jul;33(7):1618-24. Epub 2010 Apr 5. [pm id="20368409"], [pmc id="PMC2890370"], [cr id="http://dx.doi.org/10.2337/dc09-1788"]
  68. Zitzmann M., Mattern A., Hanison J., Gooren L., Jines H., Maggi M. IPASS: a study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1438. J. Sex. Med. 2013;10(2):579-588.
  69. Stanworth RD, Kapoor D, Channer KS, Jones TH. Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes. Clin Endocrinol (Oxf). 2011 May;74(5):624-30. [pm id="21470285"], [cr id="http://dx.doi.org/10.1111/j.1365-2265.2011.03969.x"]
  70. Möhlig M., Arafat A. M., Osterhoff M. A., Isken F., Weickert M. O., Spranger J., Pfeiffers A. F. H., Schöfl Ch. Androgen receptor CAG repeat length polymorphism modifies the impact of testosterone on insulin sensitivity in men. Eur. J. Endocrinol. 2011;164(6):1013-1018.
  71. Kapoor D, Clarke S, Stanworth R, Channer KS, Jones TH. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2007 May;156(5):595-602. [pm id="17468196"]
  72. Zitzmann M, Gromoll J, von Eckardstein A, Nieschlag E. The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men. Diabetologia. 2003 Jan;46(1):31-9. Epub 2002 Dec 20. [pm id="12637980"]
  73. Zitzmann M. Effects of testosterone replacement and its pharmacogenetics on physical performance and metabolism. Asian J Androl. 2008 May;10(3):364-72. Review. [pm id="18385898"], [cr id="http://dx.doi.org/10.1111/j.1745-7262.2008.00405.x"]
  74. Wiwanitkit V. CAG repeat polymorphism in the androgen receptor: a study on the effect of different numbers of repeats using Gene Ontology technique. Fertil Steril. 2009 Jan;91(1):e5-6. Epub 2008 Jan 28. [pm id="18222439"], [cr id="http://dx.doi.org/10.1016/j.fertnstert.2007.11.035"]
  75. Nielsen TL, Hagen C, Wraae K, Bathum L, Larsen R, Brixen K, Andersen M. The impact of the CAG repeat polymorphism of the androgen receptor gene on muscle and adipose tissues in 20-29-year-old Danish men: Odense Androgen Study. Eur J Endocrinol. 2010 Apr;162(4):795-804. Epub 2010 Feb 4. [pm id="20133446"], [cr id="http://dx.doi.org/10.1530/EJE-09-0763"]
  76. Walsh S, Zmuda JM, Cauley JA, Shea PR, Metter EJ, Hurley BF, Ferrell RE, Roth SM. Androgen receptor CAG repeat polymorphism is associated with fat-free mass in men. J Appl Physiol (1985). 2005 Jan;98(1):132-7. Epub 2004 Sep 17. [pm id="15377647"]
  77. Van Pottelbergh I, Lumbroso S, Goemaere S, Sultan C, Kaufman JM. Lack of influence of the androgen receptor gene CAG-repeat polymorphism on sex steroid status and bone metabolism in elderly men. Clin Endocrinol (Oxf). 2001 Nov;55(5):659-66. [pm id="11894978"]
  78. Krithivas K, Yurgalevitch SM, Mohr BA, Wilcox CJ, Batter SJ, Brown M, Longcope C, McKinlay JB, Kantoff PW. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J Endocrinol. 1999 Jul;162(1):137-42. [pm id="10396030"]
  79. Stanworth RD, Akhtar S, Channer KS, Jones TH. The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study. Eur J Endocrinol. 2013 Dec 21;170(2):193-200. Print 2014 Feb. [pm id="24165020"], [cr id="http://dx.doi.org/10.1530/EJE-13-0703"]
  80. Skjaerpe PA, Giwercman YL, Giwercman A, Svartberg J. Androgen receptor gene polymorphism and sex hormones in elderly men: the Tromsø study. Asian J Androl. 2009 Mar;11(2):222-8. Epub 2009 Jan 12. [pm id="19137002"], [pmc id="PMC3735021"], [cr id="http://dx.doi.org/10.1038/aja.2008.7"]
 

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.